Immunopharmacological aspects of bronchial asthma.
D000707:Anaphylaxis / Q000139:chemically induced / Q000209:etiology / Q000276:immunology; D000818:Animals; D000937:Antigen-Antibody Reactions; D001249:Asthma / Q000188:drug therapy / Q000209:etiology / Q000276:immunology* / Q000503:physiopathology; D001491:Basophils / Q000276:immunology; D001980:Bronchi / Q000473:pathology; D004205:Cromolyn Sodium / Q000494:pharmacology; D000242:Cyclic AMP / Q000032:analysis; D003571:Cytochalasin B / Q000494:pharmacology; D003601:Cytotoxicity Tests, Immunologic; D004049:Diethylcarbamazine / Q000494:pharmacology; D004804:Eosinophils / Q000276:immunology; D006632:Histamine / Q000009:adverse effects; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D007114:Immunization; D007073:Immunoglobulin E; D007074:Immunoglobulin G; D066298:In Vitro Techniques; D007705:Kinins / Q000009:adverse effects; D007962:Leukocytes / Q000032:analysis; D008407:Mast Cells / Q000276:immunology; D009092:Mucous Membrane / Q000473:pathology; D010277:Parasympathomimetics; D011453:Prostaglandins / Q000009:adverse effects; D011941:Receptors, Adrenergic / Q000276:immunology; D011950:Receptors, Cholinergic / Q000276:immunology; D013189:SRS-A / Q000009:adverse effects
D007074:Immunoglobulin G; D007705:Kinins; D010277:Parasympathomimetics; D011453:Prostaglandins; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D013189:SRS-A; D007073:Immunoglobulin E; D003571:Cytochalasin B; D006632:Histamine; D000242:Cyclic AMP; D004205:Cromolyn Sodium; D004049:Diethylcarbamazine